APA Citatie

Funakoshi, Y., Hata, N., Takigawa, K., Arita, H., Kuga, D., Hatae, R., . . . Mizoguchi, M. (2021). Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH‐wildtype glioblastoma. Cancer Med.

Chicago Style citaat

Funakoshi, Yusuke, et al. "Clinical Significance of CDKN2A Homozygous Deletion in Combination With Methylated MGMT Status for IDH‐wildtype Glioblastoma." Cancer Med 2021.

MLA citatie

Funakoshi, Yusuke, et al. "Clinical Significance of CDKN2A Homozygous Deletion in Combination With Methylated MGMT Status for IDH‐wildtype Glioblastoma." Cancer Med 2021.

Let op: Deze citaties zijn niet altijd 100% accuraat.